Patients with ADHD show executive functioning deficits, impaired attention and behavioral control, relating to brain areas modulated by noradrenergic transmission8,9 and norepinephrine transporter (NET) expression. The gene discussed is SLC6A2; the disease is attention deficit-hyperactivity disorder.